Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
M Zöller, P Freyschmidt-Paul, M Vitacolonna, K J McElwee, S Hummel, R Hoffmann
文献索引:Clin. Exp. Immunol. 135(3) , 398-408, (2004)
全文:HTML全文
摘要
The acute phase of alopecia areata (AA) is characterized by an increase in CD44v3+ and CD44v10+ skin-infiltrating leucocytes (SkIL). Induction of a contact eczema, one of the therapeutic options in AA, can be mitigated strongly by a blockade of CD44v10. The observation that induction of a delayed type hypersensitivity (DTH) reaction abrogates an autoimmune reaction, where both responses apparently use similar effector mechanisms, is surprising and prompted us to search for the underlying mechanisms. AA-affected C3H/HeJ mice were treated with the contact sensitizer SADBE (squaric acid dibutylester) and leucocyte subpopulations and their activation state was evaluated in SkIL and draining lymph nodes. AA-affected mice exhibited an increased number of SkIL with a predominance of T lymphocytes. After treatment with the contact sensitizer SADBE recovery of SkIL was reduced and monocytes predominated. However, a significantly increased number of leucocytes was recovered from draining lymph nodes. Draining lymph node cells from untreated and treated AA mice exhibited all signs of recent activation with high-level expression of co-stimulatory and accessory molecules and an increased percentage of CD44v3+ and CD44v10+ leucocytes. In contrast, SkIL of SADBE-treated AA mice contained relatively few activated T cells and reduced numbers of CD44v3+ and CD44v10+ cells. Thus, the activation state and the distribution of leucocyte subsets in SADBE-treated AA mice are consistent with a blockade of leucocyte extravasation. Accordingly, the therapeutic effect of long-term SADBE treatment may rely on impaired leucocyte traffic.
相关化合物
相关文献:
2012-10-01
[Journal. of. Drugs in. Dermatology. 11(10) , 1228-30, (2012)]
2007-11-15
[Bioorg. Med. Chem. Lett. 17(22) , 6151-4, (2007)]
2009-07-01
[Pediatr. Ann. 38(7) , 373-9, (2009)]
2008-01-01
[Dermatitis 19(2) , 95-9, (2008)]
2009-07-01
[Pediatr. Ann. 38(7) , 388-95, (2009)]